Friedreich's ataxia is an inherited neurodegenerative disease caused by frataxin deficiency.
Introduction
Friedreich's ataxia is an inherited disease characterized by progressive symptoms of ataxia and sensory loss, often leading to gait impairment and the need for a wheelchair. A progressive and sometimes lethal cardiomyopathy is another feature and in some cases diabetes mellitis is associated. At the pathological level, degenerative changes affect certain large sensory neurons, heart cells and islet cells, thus involving a unique target tissue distribution (1). The gene was identified by genome mapping of affected kindreds, and the encoded protein, frataxin, is decreased in affected individuals most often due to a GAA repeat in the first intron of the gene (2). The protein is found primarily in mitochondria (3) . Human frataxin is synthesized on cytoplasmic ribosomes with a mitochondrial targeting sequence that mediates organelle targeting and is subsequently removed by proteolytic processing steps in the mitochondrial matrix (4) (5) (6) (7) . Deficiencies of aconitase and other mitochondrial iron-sulfur (Fe-S) proteins occur as first noted in cardiac biopsies of affected individuals (8) . Fe-S clusters are modular cofactors consisting of iron and sulfur, most often anchored by bonds joining cysteine sulfur atoms in the polypeptide chain of a protein and iron atoms of the cluster. They perform essential and diverse biochemical functions (electron transfer in cellular respiration, substrate interaction, biological signal transduction among other functions), and their biogenesis is catalyzed by a multisubunit machinery (9) . Frataxin has been a subject of intense study with contributions from many disciplines: structural biology, cell biology, genetics of model organisms, evolutionary biology, and medicine. A picture is emerging of a direct role of frataxin in the complex and highly conserved machinery of Fe-S cluster biogenesis in mitochondria. Additional functions may be mediated by direct frataxin-iron effects or by other protein-protein interactions.
hscA and hscB appeared on the isc operon. A frataxin homolog was subsequently lost in this phylogenetic lineage on two separate occasions, coinciding with loss of hscA and hscB. Frataxin's appearance in eukaryotes occurred about the time of the endosymbiotic event creating mitochondria from the purple bacterial ancestor, and it was probably acquired by mitochondria together with other components of the isc operon (10) . This notion of co-evolution of frataxin and Fe-S assembly components of the isc operon is supported by studies of primitive eukaryotes that lack typical mitochondria. In Trichomonas vaginalis, a unicellar parasite, a modified and stripped-down organelle called the hydrogenosome performs Fe-S cluster assembly and contains a frataxin homolog able to complement the phenotypic defects of a yeast mutant lacking its own frataxin (11) .
An even more severe case of organelle simplification is presented by mitosomes. These are rudimentary organelles of obligate intracellular parasites called microsporidia, and they lack respiratory complexes or mitochondrial DNA. Virtually all that remains are a few components recognizable for their homology to Fe-S cluster assembly components (e.g. Isu, Nfs1, Hsp70 homologs) and frataxin (12) . The co-retention of frataxin with these very few other components involved in Fe-S cluster assembly in the mitosome emphasizes their close functional relationship.
Mitochondrial iron accumulation
In Saccharomyces cerevisiae, Yfh1 is the yeast frataxin homolog, and the initial studies of the ∆yfh1 deletion strain described a pleiomorphic phenotype. The mutant exhibited constitutive upregulation of the cellular iron uptake system and tremendous accumulation of iron in mitochondria (13) . The accumulated iron appeared as dense aggregates in unstained electron micrographs. Chemical analyses revealed the accumulated iron was in the form of ferric phosphate micelles (14) . Many additional studies have established a close association of the mitochondrial iron accumulation phenotype and deficiency of Fe-S clusters. Cellular depletion studies in which Yfh1 was put under control of a regulated promoter and turned off recapitulated the phenotypes of deficient Fe-S cluster proteins and mitochondrial iron accumulation. If the promoter was turned on again, Fe-S clusters were restored and the accumulated iron returned to a normal distribution (15).
Other mutants of the mitochondrial Fe-S cluster assembly pathway were similarly associated with this iron homeostatic phenotype (ssq1, jac1, nfs1, others). In human cells, mitochondrial iron accumulation has also been observed, both in tissues from Friedreich's patients (e.g. heart, dorsal root ganglia) and in cultured cells engineered to exhibit stable frataxin deficiency (16) . Thus low level frataxin is associated with mitochondrial iron accumulation and Fe-S cluster deficiency in both human and yeast cells, indicating a remarkable degree of conservation of the iron homeostatic machineries (17). The presumption is that there exists a conserved regulatory Fe-S cluster protein or proteins mediating these effects. At this time however, although an unusual Fe-S cluster (liganded by glutathione and glutaredoxins) has been found to mediate control of cellular iron uptake in yeast (18, 19) , the controlling protein(s) for mitochondrial iron uptake or accumulation has not been identified for any species, and so the latter piece is still missing from our understanding.
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The steps and components involved in the biogenesis of Fe-S cluster proteins in mitochondria are quite similar to those in bacteria. (28, 29) . This interaction is modulated by the ATP hydrolysis cycle in conjunction with accessory proteins Jac1 and Mge1
here (31) . The proteins destined to become Fe cytoplasmic ribosomes as precursor proteins with mitochondrial targeting sequences. Upon import into mitochondria, the unfolded precursors are subjected to various processing steps that remove the targeting sequences (32), and the mature apoproteins thus generated become substrates for transfer of Fe-S clusters from Isu ( Fig. 1) . conjunction with accessory proteins Jac1 and Mge1 (30) . A monothiol glutaredoxin is also implicated . The proteins destined to become Fe-S cluster proteins in mitochondria are cytoplasmic ribosomes as precursor proteins with mitochondrial targeting sequences. Upon import into mitochondria, the unfolded precursors are subjected to various processing steps that remove the , and the mature apoproteins thus generated become substrates for transfer A completely independent set of observations led to a similar conclusion. The manganese superoxide dismutase (MnSod), the dismutase of the mitochondrial matrix, was found to incorporate iron instead of manganese in some settings, with concomitant inactivation of the enzyme. For example, some of the Fe-S cluster assembly mutants with a mitochondrial iron accumulation phenotype were associated with MnSod mismetallation. Specifically, these mutants, such as ssq1 and grx5, belonged to Isu downstream events in transfer of Fe-S cluster intermediates to apoproteins (35) . By contrast, although frataxin mutants (∆yfh1) dramatically accumulated iron in mitochondria, the iron was not available for (mis)incorporation into MnSod (36) . Similarly Isu mutants (depletion or dominant negatives) were also not associated with MnSod inactivation (35) .
These data suggest frataxin should be grouped with Isu in the upstream part of the Fe-S cluster biogenesis pathway and distinguished from Ssq1 and Grx5. Although mismetallation is an aberrant situation, these observations may point to a physiological role of frataxin in modulating bioavailable iron pools in mitochondria. 
Effects of frataxin in promoting Fe-S cluster assembly in mitochondria
Two experiments are presented to illustrate the role of frataxin in promoting Fe-S cluster assembly in mitochondria. In the first experiment, mitochondria were isolated from wild-type or ∆yfh1 strains. New synthesis of Fe-S clusters in the isolated organelles was examined by providing 35 S-cysteine as a source of sulfur. In the wild-type, radioactive sulfur was incorporated into a pool of apoaconitase by the mitochondrial Fe-S cluster machinery. Synthesis of new clusters was also detected by labeling of imported ferredoxin, and these could be distinguished by signals on a native gel ( Fig. 2A, left panel; Fig. 2B, lanes 1 and 2) . In the mutant, however, no such labeling occurred, indicating failure to make Fe-S clusters ( Fig. 2A, middle panel; Fig. 2B , lanes 5 and 6).
Subsequently, frataxin was imported into the ∆yfh1 mutant mitochondria and the mitochondria were recovered by centrifugation. When a similar 35 S-cysteine labeling experiment was performed, the mutant mitochondria demonstrated restored ability to make Fe-S clusters on both aconitase and imported ferredoxin ( Fig. 2A, right panel; Fig. 2B , lanes 7 and 8). Thus a very small amount of frataxin (estimated less than one picomole) imported into isolated ∆yfh1 mitochondria even without iron addition was able to rapidly (in less than 10 minutes) restore Fe-S cluster synthesizing activity.
This effect in isolated mitochondria shows that everything is present in mitochondria for Fe-S cluster formation and that a small quantity of frataxin activates or mediates the process (25).
In the second experiment, a more reductionist approach was taken with purified proteins. Isu was expressed and purified from bacteria in the apoprotein form, without any cluster. If Isu was incubated with elemental iron and sulfur, a small amount of Fe-S cluster intermediate could be detected as shown by appearance of the characteristic absorption spectrum (Fig. 3, tracing B) . In a parallel incubation, Isu was added to elemental sulfur and iron loaded frataxin monomer instead of elemental iron alone. The absorbance tracing (Fig. 3, tracing A) followed over time showed tremendous facilitation in the presence of frataxin. In this experiment, Drosophila frataxin was used because of its greater stability, and a D37A mutant of yeast Isu was used to trap and stabilize the intermediate on Isu (37) . A similar assay showed activity of human frataxin in facilitating Fe-S cluster formation on the human Isu scaffold protein (38). These experiments with purified components demonstrate that frataxin possesses the ability to facilitate Fe-S cluster formation on Isu. conserved residues that appears to be well suited to mediate interaction with a protein partner.
Isu interaction
A functional relationship of frataxin and Isu was initially suggested by genetic experiments showing synthetic lethality of ∆yfh1 (YFH1 gene deleted) and ∆isu1 (deletion of one of two homologous ISU genes causing lowered levels of Isu) (44) . Physical interactions between frataxin and Isu were subsequently demonstrated in pull-down experiments from mitochondrial lysate.
Interestingly the pull-down of Yfh1 by Isu, or reciprocally of Isu by Yfh1, was dependent on iron addition to the buffer (50 µM ferrous ammonium sulfate), and then inhibited by the presence of the metal chelator EDTA (45). The clearest demonstration of the importance of frataxin-Isu interaction in Fe-S cluster assembly was provided by careful analyses of mutant alleles of frataxin that failed to interact. A frataxin mutant (N122A/K123T/Q124A) was constructed by alteration of conserved surface exposed residues of the strand 3 in an area predicted to mediate protein interactions (46)( Table 1 , column 1). These mutations did not interfere with protein expression or stability, and in vitro studies showed no effect on iron binding. However, interaction with Isu was severely impaired as assessed by pull-down from mitochondrial lysates onto immobilized Yfh1-His6. In these experiments, the affinity of frataxin binding to Isu was markedly decreased from about 1 µM for the wild-type to a number greater than 12 µM for the mutant. Experiments with purified Yfh1 and Isu1, as distinguished from lysate containing these and other proteins, also showed the interaction and the reduced affinity of the mutant, confirming that the mutational effect was direct. Importantly, in vivo experiments performed with the same yfh1 mutant demonstrated reduced Fe-S cluster protein activities and increased iron accumulation in mitochondria. The N122K mutant similarly was associated with decreased Isu interaction and decreased Fe-S cluster enzyme activities. The N122K mutation corresponds to N146K in the human ortholog and has been associated with Friedreich's ataxia. The wild-type and mutant proteins placed under control of a regulated promoter and expressed over a wide range of concentrations confirmed mutant phenotypes occurred over a wide range of expression levels (46). Other mutations were constructed that altered amino acids in exposed areas of the beta sheet (Q129A in strand 4, W131A in strand 4 and R141A in strand 5).
These mutations were examined in vitro and in vivo, and they too showed decreased frataxin-Isu interaction and deficiency of Fe-S cluster proteins (47) (Table 1, column 2, Fig. 4 ). The studies with mutant alleles were especially informative because they avoided many of the secondary phenotypes associated with the yfh1 deletion. The conclusion from these studies is the interaction between frataxin and Isu is required for Fe-S cluster assembly in the mitochondria. 
Iron binding
Frataxins interact with iron in vitro, although not in the manner of typical iron binding proteins.
Binding is relatively low affinity, occurs on the protein surface rather than in a cavity, and is mediated primarily by carboxylic amino acids rather than cysteines and histidines (48) 
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Some frataxins oligomerize when exposed to iron. Exposure of yeast or molar excess of elemental iron in the absence of competing cations induced oligomerization, but this did not occur with the human protein alanine completely abrogated iron dependent oligomerization of the yeast protein (Table 2 , column 1, Fig. 4 ). This triple mutant, when tested protein activities and iron homeostasis, even when expressed at low levels oligomerization is probably not required for Fe both in vitro and in vivo assays within yeast. A D79A/D82A mutation abrogated ferroxidase activity.
The D79A/D82A or E93A/D97A/E103A mutants showed decreased frataxin vitro, and both of these mutant alleles were associated with increased oxidant sensitivity and decreased life span in vivo. However, these mutations had no effect on aconitase activity and no effect on mitochondrial iron accumulation important for Fe-S cluster biogenesis.
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Some frataxins oligomerize when exposed to iron. Exposure of yeast or E. coli molar excess of elemental iron in the absence of competing cations induced oligomerization, but this did not occur with the human protein (51). Mutation of three carboxylates D86, E90, and E93 to alanine completely abrogated iron dependent oligomerization of the yeast protein (Table 2 , column e mutant, when tested in vivo, showed no deleterious effects on Fe protein activities and iron homeostasis, even when expressed at low levels bly not required for Fe-S cluster synthesis. Other mutations were tested in assays within yeast. A D79A/D82A mutation abrogated ferroxidase activity.
The D79A/D82A or E93A/D97A/E103A mutants showed decreased frataxin-, and both of these mutant alleles were associated with increased oxidant sensitivity and . However, these mutations had no effect on aconitase activity and no effect on mitochondrial iron accumulation (53) ( Table 2 , column 2), and thus they are probably not S cluster biogenesis.
E. coli frataxins to 20-fold molar excess of elemental iron in the absence of competing cations induced oligomerization, but this . Mutation of three carboxylates D86, E90, and E93 to alanine completely abrogated iron dependent oligomerization of the yeast protein (Table 2, column , showed no deleterious effects on Fe-S cluster protein activities and iron homeostasis, even when expressed at low levels (52) . Thus frataxin S cluster synthesis. Other mutations were tested in assays within yeast. A D79A/D82A mutation abrogated ferroxidase activity. iron interactions in , and both of these mutant alleles were associated with increased oxidant sensitivity and . However, these mutations had no effect on aconitase activity and no (Table 2 , column 2), and thus they are probably not By contrast, mutation of four acidic residues D86/E89/D101/E103 to alanine was more deleterious type levels and mitochondrial iron accumulation occurred. Iron binding to this mutant frataxin was not measured directly, although iron dependent Isu interaction in mitochondrial lysate was markedly decreased (54) ( Table 2, riments illustrates the problem of redundancy in the acidic iron phenotype (compared with wildtype), regardless of the frataxin expression level. The D101/E103 mutant displayed a modest enotype with moderately lower aconitase. However, the combined mutant exhibited a severe phenotype with growth inhibition and 40% residual aconitase activity. Iron binding affinity of this ation but was not abolished (55) ( Table 2 , column 4). Interestingly, the frataxin-Isu iron dependent interaction tested with purified proteins was abrogated by the D101/E103 or the combined D886/E90/E93/D101/E103 mutations (55). We determined mutational effects of amino acids that showed strong interactions with Fe 2+ in an NMR study with 15 N-labeled Yfh1. Two possible iron binding sites were identified, one site consisting of D68/E93/H95 (site 1) and the other consisting of D101/E103 (site 2). Mutation of site 1 residues to alanine had no discernable effect on in vivo phenotypes, mutations of site 2 had a very mild effect (aconitase 90%), although iron binding stoichiometry for these mutants was decreased such that only one iron bound per molecule. Combined mutations of site 1 and site 2 showed no iron binding by ITC or NMR titrations, and the in vivo phenotypes were quite severe, with aconitase of 37%, slow growth, and mitochondrial iron accumulation. These data show a correlation of frataxin iron binding and Fe-S cluster assembly activity i.e. the mutated iron binding sites were correlated with severely compromised Fe-S cluster assembly activity (Table 2, 
How frataxin might work
In summary, frataxin interacts with the Fe-S cluster assembly scaffold protein Isu using frataxin's beta sheet surface. It also interacts with iron via surface carboxylates of the helix 1-strand 1 area. However, the affinity of frataxin for iron is relatively low and coordination incomplete, with the carboxylate binding sites being completed by water molecules. The driving force and mechanism of metal transfer to recipients also might be different than for the copper chaperones. A prediction of this model is that the iron liganding sites should overlap or be contiguous with the Isu binding sites.
This may be the case especially for the iron binding site on the strand 1 consisting of the conserved D101/E103 residues. Biochemical data suggest frataxin facilitates iron use for Fe-S cluster formation on Isu (38) (Fig. 3) . Other functions in mitochondrial iron trafficking are also possible. In 
Is Friedreich's ataxia a disease of Fe-S cluster assembly?
If Friedreich's ataxia is caused by frataxin deficiency and frataxin mediates Fe-S cluster assembly, the question arises whether the disease is caused by Fe-S cluster deficiency. As far as is known, neither the cellular phenotype nor the human disease phenotype can be explained by deficiency of a single Fe-S cluster protein. Perhaps it is the combined effects from decreased activities of many Fe-S cluster proteins that produces the peculiar tissue specific effects characteristic of the disease. Also the degree of frataxin deficiency may be important for producing the unique cellular disease phenotypes. Complete lack of frataxin is lethal for growing mammalian cells, and somewhere between 20-30% is needed for normal growth. In cells with these decreased levels of frataxin, some Fe-S cluster proteins are deficient and iron accumulates in mitochondria as in the human disease different tissues depending on redundancy with other proteins and tissue specific needs. The recently demonstrated role of mitochondrial ferritin and its ability to mitigate the effects of frataxin deficiency might be important in this regard (59), and thus red cell precursors which have the ability to express mitochondrial ferritin in some settings perhaps would not be as affected by frataxin deficiency as other tissues e.g. large bore sensory neurons. An inherited disease ascribed to Isu deficiency has been described, and this is characterized by some degree of Fe-S cluster deficiency and iron accumulation in affected tissues (62, 63) . Given the close functional association of frataxin and Isu, one might expect that the human deficiencies would phenocopy each other. However in
Friedreich's ataxia, a unique tissue distribution targets dorsal root ganglia, cerebellum, and heart muscle. In the Isu deficiency disease, by contrast, the features are skeletal muscle swelling and exercise intolerance; neurodegeneration is not a feature. Thus Isu deficiency and frataxin deficiency in humans bear some resemblance but the tissue specificities are distinct with the differences still unexplained.
